RecruitingNCT00001823

Evaluation for NCI Surgery Branch Clinical Research Protocols

Sponsor

National Cancer Institute (NCI)

Enrollment

7,000 participants

Start Date

Jul 11, 1999

Study Type

OBSERVATIONAL

Conditions

Melanoma Synovial Cell Cancer

Summary

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates people being considered for treatment on cancer surgery research programs at the NCI Surgery Branch, to determine which specific treatment trials they may be eligible for. **You may be eligible if...** - You are 18 years of age or older - You have a confirmed or suspected cancer diagnosis - You understand and are willing to sign an informed consent form - You are being considered for treatment on an NCI Surgery Branch research protocol **You may NOT be eligible if...** - You are pregnant or planning to become pregnant, due to potential risks from some screening procedures (such as imaging scans) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.